glp-1 bowel obstruction lawsuit in louisiana gastric intestinal class action louisiana semaglutide gastrointestinal obstruction law firm louisiana semaglutide gastric intestinal obstruction legal team Semaglutide semaglutide digestive blockage law office

They promote weight loss by increasing insulin sensitivity, slowing gastric emptying, and reducing appetite

As of mid-2025, no Phase II or Phase III human clinical trial for BPC-157 has been completed and published in a peer-reviewed journal

Because of the controversy surrounding dysplastic naevi, the NIH held a consensus conference and attempted to explicitly define the features of dysplastic naevi

Anti-Aging Effects: May reduce the visible and systemic signs of aging by supporting overall cellular health

Glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors and risk of nonalcoholic fatty liver disease among patients with type 2 diabetes

We are committed to confronting the stigma linked with chronic diseases, like obesity, and expanding access to our authentic, prescription-only medicines. For more on weight management: Hims & Hers Super Bowl ad slams pricey pharma industryand fumbles FDA warnings on compounded GLP-1 drugs Exclusive: The COO of Hims & Hers was the third person to try its new weight-loss drugsand shes ready to share her story Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says